RMD240517C200000
- 17.83
- 0.000.00%
ResMed Newsroom
Express News | NYSE Order Imbalance 57838.0 Shares on Sell Side
ResMed Says Research Shows Effectiveness of Positive Airway Pressure Therapy For Sleep Apnea
ResMed (RMD) said Thursday new findings showed that positive airway pressure therapy decreased risks of death and hospitalization for people with obstructive sleep apnea. ResMed said several studies s
Express News | Developed in Collaboration With Leading Scientists, New Resmed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy
Here's How Much a $1000 Investment in ResMed Made 10 Years Ago Would Be Worth Today
(SEC Amendment) ResMed(RMD.US) Director Sells US$78,584.4 in Common Stock
$ResMed(RMD.US)$ Director De Witte Jan sold 360 shares of common stock on May 15, 2024 at an average price of $218.29 for a total value of $78,584.4.Source: Announcement What is statement of changes i
ResMed's (NYSE:RMD) Investors Will Be Pleased With Their Strong 101% Return Over the Last Five Years
Wall Street Analysts See ResMed (RMD) as a Buy: Should You Invest?
Here's Why Investors Should Buy ResMed (RMD) Stock Now
ResMed(RMD.US) Director Sells US$78,584.4 in Common Stock
$ResMed(RMD.US)$ Director De Witte Jan sold 360 shares of common stock on May 15, 2024 at an average price of $218.29 for a total value of $78,584.4.Source: Announcement What is statement of changes i
$100 Invested In This Stock 10 Years Ago Would Be Worth $400 Today
ResMed (NYSE:RMD) has outperformed the market over the past 10 years by 4.86% on an annualized basis producing an average annual return of 15.65%. Currently, ResMed has a market capitalization of $32.
ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy
SAN DIEGO, May 16, 2024 (GLOBE NEWSWIRE) -- When: May 17–22, 2024Where: San Diego Convention Center (SDCC) | 111 Harbor Dr. San Diego, CA 92101 Marriott Marquis
What Makes ResMed (RMD) a New Strong Buy Stock
Most Shorted S&P 500 Stocks as a Percentage of Float
Short Interest in S&P 500 Healthcare Sector Dips in April, Biotechnology Companies Most Shorted
Why ResMed (RMD) Is a Top Growth Stock for the Long-Term
U.S. Consumer Sentiment Plummets in May: 5 Safe Stock Picks
AU Evening Wrap: ASX Rally Late to Close Flat; Fletcher Plummets 11%
Consumer and health stocks were the best performers as the benchmark index rallied from almost 0.4% down over the last hour of Monday's session.
Is ResMed Inc. (NYSE:RMD) Trading At A 22% Discount?
Key Insights Using the 2 Stage Free Cash Flow to Equity, ResMed fair value estimate is US$273 ResMed is estimated to be 22% undervalued based on current share price of US$214 Our fair value estima
ResMed(RMD.US) Officer Sells US$2.75 Million in Common Stock
$ResMed(RMD.US)$ Officer Sandercock Brett sold 13,000 shares of common stock on May 8, 2024 at an average price of $211.37 for a total value of $2.75 million.Source: Announcement What is statement of
Resmed Insider Sold Shares Worth $2,747,810, According to a Recent SEC Filing
Brett Sandercock, Chief Financial Officer, on May 08, 2024, sold 13,000 shares in Resmed (RMD) for $2,747,810. Following the Form 4 filing with the SEC, Sandercock has control over a total of 92,056 s